Literature DB >> 26959803

Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma.

Flair J Carrilho1, Angelo Alves de Mattos2, Alex F Vianey3, Denise Cerqueira P Vezozzo1, Fábio Marinho4, Francisco J Souto5, Helma P Cotrim6, Henrique Sergio M Coelho7, Ivonete Silva8, José Huygens P Garcia9, Luciana Kikuchi1, Patricia Lofego10, Wellington Andraus4, Edna Strauss1, Giovanni Silva11, Isaac Altikes12, Jose Eymard Medeiros13, Paulo L Bittencourt14, Edison R Parise8.   

Abstract

Hepatocellular carcinoma is a malignancy of global importance and is associated with a high rate of mortality. Recent advances in the diagnosis and treatment of this disease make it imperative to update the recommendations on the management of the disease. In order to draw evidence-based recommendations concering the diagnosis and management of hepatocellular carcinoma, the Brazilian Society of Hepatology has sponsored a single-topic meeting in João Pessoa (PB). All the invited pannelists were asked to make a systematic review of the literature and to present topics related to the risk factors for its development, methods of screening, radiological diagnosis, staging systems, curative and palliative treatments and hepatocellular carcinoma in noncirrhotic liver. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of those recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present paper is the final version of the reviewed manuscript containing the recommendations of the Brazilian Society of Hepatology.

Entities:  

Mesh:

Year:  2015        PMID: 26959803     DOI: 10.1590/S0004-28032015000500001

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  4 in total

Review 1.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

2.  A systematic review of publications on charged particle therapy for hepatocellular carcinoma.

Authors:  Hiroshi Igaki; Masashi Mizumoto; Toshiyuki Okumura; Kiyoshi Hasegawa; Norihiro Kokudo; Hideyuki Sakurai
Journal:  Int J Clin Oncol       Date:  2017-09-04       Impact factor: 3.402

3.  Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study.

Authors:  Marcelo Campos Appel-da-Silva; Suelen Aparecida da Silva Miozzo; Isabella de Azevedo Dossin; Cristiane Valle Tovo; Fernanda Branco; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

4.  The ALPPS procedure for hepatocellular carcinoma larger than 10 centimeters.

Authors:  Orlando Jorge M Torres; Rodrigo Rodrigues Vasques; Thiago Henrique S Silva; Miguel Eugenio L Castelo-Branco; Camila Cristina S Torres
Journal:  Int J Surg Case Rep       Date:  2016-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.